Under an agreement announced Monday, Feb. 23, Organon will pay $27.5 million upfront for the right to market Sebela’s Miudella, billed as the first FDA-approved device of its kind in 40 years.
Verywell Health on MSN

IUD use in nulliparous women

Medically reviewed by Andrea L. Braden, MD Key Takeaways The FDA has now approved IUDs for women who have never given ...
Organon (NYSE: OGN), a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, announced today that it has entered into an agreement to ...
According to Sebella Women’s Health, Miudella has similar efficacy to the currently available copper IUDs but with less than half the dose of copper. The Food and Drug Administration (FDA) has ...
Nonhormonal copper IUDs of different sizes can benefit different body types. About one in five women may discontinue IUD use within a year, often due to increased bleeding and cramping. A smaller IUD ...
Medically reviewed by Renita White, MD Key Takeaways IUDs can last a long time and don't need daily care.IUDs are over 99% ...
The most common side effect after getting an IUD inserted is cramping. Hormonal IUDs like Mirena can make your period lighter and, in some cases, stop it altogether. Non-hormonal copper IUDs can cause ...
Please provide your email address to receive an email when new articles are posted on . Women with Liletta and Mirena IUDs were more likely to have rosacea 1-year after insertion vs. those with copper ...
Intrauterine devices (IUDs) are a popular form of long-acting reversible contraception (LARC), offering effective and low-maintenance birth control for women. According to the Centers for Disease ...
Add Yahoo as a preferred source to see more of our stories on Google. One positive trend in women’s health in the past several years is the fact that for the first time, the pain women experience ...